Evidence map›Paper›PMID 30403754›Full record

ArticlePloS one2018

Metabolomic insights of macrophage responses to graphene nanoplatelets: Role of scavenger receptor CD36.

Sherleen Xue-Fu Adamson, Ruoxing Wang, Wenzhuo Wu, Bruce Cooper, Jonathan Shannahan

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sherleen Xue-Fu AdamsonSchool of Health Sciences, Purdue University, West Lafayette, IN, United States of America.
Ruoxing WangSchool of Industrial Engineering, Purdue University, West Lafayette, IN, United States of America.
Wenzhuo WuSchool of Industrial Engineering, Purdue University, West Lafayette, IN, United States of America.
Bruce CooperMetabolite Profiling Facility in Bindley Biosciences Center, Discovery Park, Purdue University, West Lafayette, IN, United States of America.
Jonathan ShannahanSchool of Health Sciences, Purdue University, West Lafayette, IN, United States of America.ORCID 0000-0002-1065-7810
Purdue University West Lafayette · US

Funding

Disease-Induced Modification in Nanoparticle-Corona Identity and ToxicityR00ES024392 · NIEHS · PURDUE UNIVERSITY · PI SHANNAHAN, JONATHAN HENRY · 2017 to 2019
$747k
NIEHS NIH HHS R00 ES024392
6 · The paper itself

Abstract

Graphene nanoplatelets (GNPs) are novel two-dimensional engineered nanomaterials consisting of planar stacks of graphene. Although human exposures are increasing, our knowledge is lacking regarding immune-specific responses to GNPs and mechanisms of interactions. Our current study utilizes a metabolite profiling approach to evaluate macrophage responses to GNPs. Furthermore, we assessed the role of the scavenger receptor CD36 in mediating these GNP-induced responses. GNPs were purchased with dimensions of 2 μm × 2 μm × 12 nm. Macrophages were exposed to GNPs at different concentrations of 0, 25, 50, or 100 μg/ml for 1, 3, or 6 h. Following exposure, no cytotoxicity was observed, while GNPs readily associated with macrophages in a concentration-dependent manner. After the 1h-pretreatment of either a CD36 competitive ligand sulfo-N-succinimidyl oleate (SSO) or a CD36 specific antibody, the cellular association of GNPs by macrophages was significantly reduced. GNP exposure was determined to alter mitochondrial membrane potential while the pretreatment with a CD36 antibody inhibited these changes. In a separate exposure, macrophages were exposed to GNPs at concentrations of 0, 50, or 100 μg/mL for 1 or 3h or 100 μM SSO (a CD36 specific ligand) for 1h and collected for metabolite profiling. Principal component analysis of identified compounds determined differential grouping based on exposure conditions. The number of compounds changed following exposure was determined to be both concentration- and time-dependent. Identified metabolites were determined to relate to several metabolism pathways such as glutathione metabolism, Pantothenate and CoA biosynthesis, Sphingolipid metabolism, Purine metabolism, arachidonic acid metabolism and others. Lastly, a number of metabolites were found in common between cells exposed to the CD36 receptor ligand, SSO, and GNPs suggesting both CD36-dependent and independent responses to GNP exposure. Together our data demonstrates GNP-macrophage interactions, the role of CD36 in the cellular response, and metabolic pathways disrupted due to exposure.

Indexed as

MetabolomicsNanostructuresAnimalsCD36 AntigensCell SurvivalDose-Response Relationship, DrugGraphiteMacrophagesMembrane Potential, MitochondrialMiceRAW 264.7 CellsCD36 AntigensGraphite

Identifiers

PMID30403754
PMCPMC6221354
OpenAlexW2899722029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.